glutathione parkinsons disease therapy perlmutter Potential use of as a treatment for Parkinson's UC Irvine researchers are closing
UC Irvine researchers are closing in on the mysterious origins of Parkinson's disease, which affects nearly one million people in the United States. Evidence suggests that the incurable disorder may begin in Perlmutter named scientific director of dystonia foundation WashU Medicine Randomized, doubleblind, pilot evaluation of intravenous glutathione in Parkinson's disease Hauser 2009 Movement Disorders Wiley Online Library Levodopa and the Progression of Parkinson's Disease New England Journal of Medicine
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


